4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-013471
Principal Accounting Officer sold 350 shares at $18.78 ($6,573)
- Principal Accounting Officer acquired 840 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kihara James Principal Accounting Officer | 2023-02-23 | Option exercise | +840 | 3,273 | D | ||
| Kihara James Principal Accounting Officer | 2023-02-24 | Sale | −350 | $18.78 | $6,573 | 2,923 | D |
| Derivatives | |||||||
| Kihara James Principal Accounting Officer | 2023-02-23 | Option exercise · Restricted Stock Units | −840 | 1,680 | D | ||
| Open-market sales · 350 sh · avg $18.78 · $6,573 | |||||||
Loading xslF345X03/doc4.xml…